Jared Leto to Star as ‘Morbius,’ Daniel Espinosa Set to Direct

Avi Arad and Matt Tolmach will produce with Lucas Foster

Last Updated: June 27, 2018 @ 1:38 PM

Oscar winner Jared Leto will star in and Daniel Espinosa will direct “Morbius,” based on the Marvel comic, an individual with knowledge of the project told TheWrap on Wednesday.

Avi Arad and Matt Tolmach will produce with Lucas Foster. Palak Patel will oversee for the studio.

Matt Sazama and Burk Sharpless wrote the script.

The Morbius character was created by Roy Thomas and Gil Kane and first appeared in “The Amazing Spider-Man” issue no. 101 in 1971. In the comics, Michael Morbius is a Nobel Prize-winning biochemist who is transformed into a vampire while attempting to cure a rare blood disease with a highly experimental approach involving electroshock therapy… and vampire bats.

Oh, and Spider-Man had six arms at the time. It was temporary.

Morbius Sony Marvel Vampie

As a “pseudo-vampire,” Morbius does not possess all the powers of an actual vampire, and isn’t subject to all the traditional limitations and weaknesses thereof, according to Marvel lore.

He must digest blood to survive and has a strong aversion to light, like most vampires. But he also has the ability to fly, and superhuman strength, speed and healing abilities. His bite tends to be lethal, but his victims do not necessarily become vampires themselves.

Morbius almost made it to the big screen before. In 2000, when Avi Arad was president and CEO of Marvel Studios, the company entered into an agreement with Artisan Entertainment to turn at least 15 Marvel superhero franchises into live-action films, television series, direct-to-video films or internet projects. Morbius would have been among the franchises.

Sazama and Sharpless’ recent credits include “Gods of Egypt,” “The Last Witch Hunter” and “Dracula Untold.”

Sazama and Sharpless are represented by ICM Partners and the SMGS law firm.

Espinosa is repped by WME, Magnolia Entertainment and Warren Dern.

Keep
Reading...

Looks like you’re enjoying reading
Keep reading by creating
a free account or logging in.